Cardiogen
Tetrapeptide (Ala-Glu-Asp-Arg) from the Khavinson cytomedin lineage. Targeted at cardiac tissue — Russian Academy work claims restoration of myocardial function indices in aging + post-infarct cohorts.
How it clearsHalf cleared in ~3h. Most (~96%) gone by ~15h.
Compare these compounds
Mechanism, evidence, legal path, cost — all side-by-side.
This compound sits in research-grey territory. The caveats below carry more weight than for FDA-approved entries — read them.
Same Khavinson cytomedin framework — tissue-specific tetrapeptide bioregulator with gene-regulation mechanism hypothesis. Cardiac indication-specific publications from Khavinson + St. Petersburg gerontology groups; western RCT replication is absent. Cohort use is biohacker-niche in the West; cardiologist adoption is limited even in Russia outside the Khavinson school.
Khavinson-lineage evidence only. Identity-verification problem for grey-market imports. NOT a substitute for evidence-based cardiac pharmacotherapy in coronary-artery-disease or heart-failure patients. Cardiologist supervision is non-negotiable in any cardiac-comorbid cohort.
Upload your data to see how it relates to Cardiogen.
Upload a lab file (LabCorp / Quest) or DNA file (23andMe / AncestryDNA). Stack will show your specific markers alongside the literature-reported response windows.
Upload in /historyPer-claim grading. Each claim is graded independently — same peptide, different claims can carry different grades.
- DMechanistic / anecdotal
Cardiogen — primary mechanism: tetrapeptide (ala-glu-asp-arg) from the khavinson cytomedin lineage. targeted at cardiac tissue — russian academy work claims restoration of myocardial function indices in aging + post-infarct cohorts.
1 supporting referencesVerified 13d ago
External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.
Russian regulatory pathway only · grey-market import for US/EU · no Western RCT body
Pre-filled with this compound's published dose range: 5-10 mg subcutaneous (Khavinson protocol) · daily × 10 days, 1-2× yearly
Draw volume exceeds 100 units (1 mL). Either reduce dose or split into multiple injections.
Calculator is a discussion tool. Verify reconstitution + dosing with a qualified provider. Stack is not a prescription source. Use sterile technique and inspect every vial.
No field reports yet
Field reports are added as users share their real-world protocols.
Next visit & citations
Handoff & sources
Running this compound? Log it in /history, then open Dr Passport before your visit. Methodology explains grades; the research dashboard sorts the full catalog with citations.